team board of directors scientific advisory team alliances and collaborations research & development programs clinical oncology programs sapacitabine cyc682 seliciclib cyc202 other programs science and technology cell cycle in cancer drug discovery & development approach clinical trials publications investors & media corporate governance board of directors committee composition management team common stock information news sec filings analysts corporate presentations & events corporate factsheet annual reports request investor pack alerting service careers contact cell cycle pioneers improving patients healthcare with orally available innovative medicines cyclacel pharmaceuticals inc. nasdaq cycc nasdaq cyccp is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases . our pipeline applying its core strength in cell cycle biology cyclacel is advancing a pipeline of orally available small molecule investigational drugs designed to stop uncontrolled cell division . sapacitabine our lead drug candidate is being evaluated in the seamless pivotal phase 3 trial in elderly patients with acute myeloid leukemia under a special protocol assessment agreement with the us food and drug administration . for more information on our investigational drug programs and clinical trials please go to the research & development tab above . learn more about our clinical trials sapacitabine cyc682 an oral nucleoside analogue prodrug that acts through a novel mechanism . seliciclib cyc202 a novel first in class orally available cyclin dependent kinase cdk inhibitor . cyc065 a highly selective orally available 2nd generation inhibitor of cyclin dependent kinases cdk 2 and 9 . perspectives sapacitabine patient seliciclib patient investigator details common stock info nasdaqcm cycc us delayed at least 20 minutes . provided by esignal . healtheo360 presents exchange a conversation with spiro rombotis from cyclacel ; acute myeloid leukemia watch the video on the healtheo360 website website created by princeton internet group ping sitemap privacy disclaimer contact us alerting service copyright 1997 2016 cyclacel pharmaceuticals inc. .